MarketCap
Mirum Pharmaceuticals MIRM
$ 89.7
0.38%
Facebook
X
Telegram
Mirum Pharmaceuticals Total Inventories | MIRM
Annual Total Inventories Mirum Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.9 M | 22.4 M | 22.3 M | 5.56 M | 1.51 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.9 M | 1.51 M | 15.3 M |
Quarterly Total Inventories Mirum Pharmaceuticals
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.8 M | 25.5 M | 24 M | 22.9 M | 22.4 M | 22.4 M | 21.6 M | 20.4 M | 21.6 M | 22.3 M | 22.2 M | 8.51 M | 6.61 M | 5.56 M | 6.94 M | - | 1.58 M | 1.51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25.8 M | 1.51 M | 16.6 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Clovis Oncology
CLVS
|
13.7 M | - | -7.23 % | $ 13 M |  USA |
 |
BioMarin Pharmaceutical
BMRN
|
1.3 B | $ 60.26 | 0.06 % | $ 11.6 B | USA |
 |
Catalyst Biosciences
CBIO
|
6.34 M | $ 13.99 | 0.84 % | $ 1.25 B | USA |
 |
Codexis
CDXS
|
1.82 M | $ 1.32 | 1.09 % | $ 115 M | USA |
 |
Cerus Corporation
CERS
|
56.1 M | $ 2.62 | 0.38 % | $ 499 M | USA |
 |
G1 Therapeutics
GTHX
|
12.4 M | - | - | $ 370 M | USA |
 |
Coherus BioSciences
CHRS
|
3.17 M | $ 1.13 | 0.43 % | $ 132 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
573 K | $ 4.25 | 3.16 % | $ 51.9 M |  Israel |
 |
AbbVie
ABBV
|
4.95 B | $ 264.34 | 0.09 % | $ 468 B | USA |
 |
Cocrystal Pharma
COCP
|
1.65 M | $ 1.17 | 1.74 % | $ 13.2 M | USA |
 |
AbCellera Biologics
ABCL
|
6.34 M | $ 12.7 | 0.4 % | $ 3.79 B |  Canada |
 |
Abeona Therapeutics
ABEO
|
5.49 M | $ 5.4 | 2.65 % | $ 286 M | USA |
 |
Collegium Pharmaceutical
COLL
|
40.9 M | $ 22.53 | 0.2 % | $ 713 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
12.9 M | $ 116.1 | 4.93 % | $ 12.1 B | USA |
 |
CorMedix
CRMD
|
29.7 M | $ 7.85 | 1.03 % | $ 565 K | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
2.02 M | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
CEL-SCI Corporation
CVM
|
1.02 M | $ 1.67 | 2.38 % | $ 13.4 M | USA |